EUVIMEDEUVIMED entdecken
Crossref

Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo

Kazuto Yamazaki, Kenji Kubara, Yuta Suzuki, Taro Hihara, Daisuke Kurotaki, Tomohiko Tamura, Masashi Ito, Kappei Tsukahara

European Journal of Pharmaceutics and Biopharmaceutics · 2023

DOI: 10.1016/j.ejpb.2022.12.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023. Verfasst von Kazuto Yamazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: k5-yamazaki@hhc.eisai.co.jp. Hauptthemen laut MEDLINE: Mannose, Macrophages. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Eisai Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid therapeutics have been utilized for gene regulation, and their recent advancement has led to approval of novel drugs for liver-related disorders. However, systemic extrahepatic delivery remains challenging. Here, we report newly designed mannose-conjugated oligonucleotides for delivering oligonucleotides to macrophages by leveraging the mannose receptor, C-type 1 (MRC1, CD206), which is abundantly expressed in macrophages. We investigated the relationship between cellular uptake and multivalency (mono to tetra) of mannose ligands or linker length and selected a trivalent-mannose ligand. Trivalent-mannose (Man3)-conjugated siRNA induced concentration-dependent gene silencing in both human CD206-overexpressing cells and human macrophages in vitro. After subcutaneous injection into mice, we observed a high distribution of Man3-conjugated oligonucleotides in the liver and pancreata as well as cellular uptake into Kupffer cells and pancreatic macrophages. A single subcutaneous injection of Man3-conjugated siRNA (10 mg/kg) targeting β2-microglobulin (B2M) silenced B2m mRNA expression by ∼50% and decreased its protein levels in mouse pancreatic macrophages compared to those in saline-treated mice. Of note, multiple subcutaneous injections decreased B2m gene expression and B2M protein levels by ∼80% and ∼85%, respectively. These results show that mannose-conjugation with oligonucleotides is expected to help deliver oligonucleotides to macrophages and regulate gene expression in vivo, particularly in the pancreas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MannoseMacrophagesHumansAnimalsMiceRNA, Small InterferingGene SilencingLigandsPancreasOligonucleotides

Stichwörter der Autor:innen

CD206MacrophagesMannose ligandsNucleic acid therapeuticsPancreas

Substanzen

RNA, Small InterferingMannoseLigandsOligonucleotides

Autor:innen und Institutionen

  • Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: k5-yamazaki@hhc.eisai.co.jp.
  • Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Department of Immunology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

Förderung

  • Eisai Canada

Zitieren

APA

Yamazaki, K., Kubara, K., Suzuki, Y., Hihara, T., Kurotaki, D., Tamura, T., Ito, M., & Tsukahara, K. (2023). Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2022.12.017

Vancouver

Yamazaki K, Kubara K, Suzuki Y, Hihara T, Kurotaki D, Tamura T, et al. Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 2023. doi:10.1016/j.ejpb.2022.12.017

BibTeX
@article{Yamazaki2023,
  author = {Yamazaki, Kazuto and Kubara, Kenji and Suzuki, Yuta and Hihara, Taro and Kurotaki, Daisuke and Tamura, Tomohiko and Ito, Masashi and Tsukahara, Kappei},
  title = {Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  doi = {10.1016/j.ejpb.2022.12.017}
}
Kostenlos starten →